<DOC>
	<DOCNO>NCT02712034</DOCNO>
	<brief_summary>The primary aim study measure explain impact long-term opioid use medication-assisted treatment ( MAT ) bundle evidence-based mobile-health system ( A-CHESS ) .</brief_summary>
	<brief_title>Impact Opioid Use Bundling Medication-assisted Treatment With mHealth</brief_title>
	<detailed_description />
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>1. 18+ year old ; 2. meet criterion opioid use disorder least moderate severity ( 4 5 DSMV criterion ) ; 3 . Are currently take medicationassisted treatment ( MAT ) part standard clinical care ; 4. acute medical problem require immediate inpatient treatment ; 5. history psychotic disorder , though comorbid psychopathology ( mood disorder , anxiety , substance use disorder ) eligible ; 6. willing participate randomize clinical trial ; 7. provide name , verify telephone number , address least 2 contact willing help locate patient , necessary , followup ; 8. able read write English ; 9. pregnant ; 10. willing share healthrelated data primary care clinician ; 11. , study intake , abstinent opioids least 1 week longer 2 month , except medication use treat disorder ( e.g. , methadone ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Medication-assisted treatment ( MAT )</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Methadone</keyword>
	<keyword>Naltrexone</keyword>
</DOC>